RECOPHARMA, the MSCA project we contributed to as a consortium partner, has been selected among more than 100 success stories in the European Commission’s MSCA 30th Anniversary publication.
Over 2018–2023, the project brought universities, an SME and Cuban research centres together through MSCA RISE staff exchanges. One of the materials they developed removed 90% of cytostatic drug traces from wastewater in a treatment-plant test.
Being part of a project the European Commission chose to represent 30 years of MSCA impact is a real highlight for our team. Congratulations to the coordinator, Universitat Autònoma de Barcelona, and to all RECOPHARMA partners! 👏
🔗 https://op.europa.eu/webpub/eac/msca-30-years/en/projects/recopharma.html
#MSCA30 #MSCA #RECOPHARMA #Horizon2020 #EUprojects #ResearchImpact
2025 © Europe for Business (EFB) All Rights Reserved. | Powered By Webpristine Technology